Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].
Remyelination therapy goes to trial for multiple sclerosis.
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 T.
Regulatory T Cells in Central Nervous System Injury: A Double-Edged Sword.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Progression of Relapsing-Remitting Demyelinating Disease Does Not Require Increased TCR Affinity or Epitope Spread.
The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.
Proteinase-activated receptor 2: Are common functions in glial and immune cells linked to inflammation-related CNS disorders?
Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis.
Interferon treatment of multiple sclerosis.
Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
Looking out for the blind spot.
[The CD100 semaphorin expression on peripheral blood T-lymphocytes in patients with relapsing-remitting multiple sclerosis.]
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide.
Serum complement factor and Tyr4O2 His gene polymorphism among Egyptians with multiple sclerosis.
We-Measure: Toward a low-cost portable posturography for patients with multiple sclerosis using the commercial Wii balance board.
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor.
The contribution of optical coherence tomography in neurodegenerative diseases.
Pages
« first
‹ previous
…
611
612
613
614
615
616
617
618
619
…
next ›
last »